Journal Title：European Journal Of Clinical Investigation

EJCI considers any original contribution from the most sophisticated basic molecular sciences to applied clinical and translational research and evidence-based medicine across a broad range of subspecialties. The EJCI publishes reports of high-quality research that pertain to the genetic, molecular, cellular, or physiological basis of human biology and disease, as well as research that addresses prevalence, diagnosis, course, treatment, and prevention of disease. We are primarily interested in studies directly pertinent to humans, but submission of robust in vitro and animal work is also encouraged. Interdisciplinary work and research using innovative methods and combinations of laboratory, clinical, and epidemiological methodologies and techniques is of great interest to the journal. Several categories of manuscripts (for detailed description see below) are considered: editorials, original articles (also including randomized clinical trials, systematic reviews and meta-analyses), reviews (narrative reviews), opinion articles (including debates, perspectives and commentaries); and letters to the Editor.

EJCI 考虑从最复杂的基础分子科学到广泛的亚专业的应用临床和转化研究以及循证医学的任何原创性贡献。 EJCI 发表与人类生物学和疾病的遗传、分子、细胞或生理学基础相关的高质量研究报告，以及针对疾病的患病率、诊断、病程、治疗和预防的研究。我们主要对与人类直接相关的研究感兴趣，但也鼓励提交可靠的体外和动物研究。该杂志对使用创新方法以及实验室、临床和流行病学方法和技术组合的跨学科工作和研究非常感兴趣。考虑了几类手稿（详细描述见下文）：社论、原创文章（也包括随机临床试验、系统评价和荟萃分析）、评论（叙述性评论）、意见文章（包括辩论、观点和评论）；和给编辑的信。